These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 794846)

  • 41. [Prophylactic measures for preventing renal osteodystrophy].
    Seidel A; Ritz E
    Verh Dtsch Ges Inn Med; 1989; 95():248-52. PubMed ID: 2603483
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of vitamin D on in vitro bone calcium metabolism.
    Au WY; Bartter FC
    Endocrinology; 1966 Jun; 78(6):1100-4. PubMed ID: 5920690
    [No Abstract]   [Full Text] [Related]  

  • 43. Progressive renal osteodystrophy.
    Peacock E
    ANNA J; 1988 Dec; 15(6):360, 370. PubMed ID: 3214203
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hyperparathyroidism in chronic renal insufficiency new clinical and surgical aspects (author's transl)].
    Kovarik J; Roka R; Stummvoll HK; Graf H; Niederle P; Woloszczuk W; Wolf A; Pinggera WF; Fritsch A
    Wien Klin Wochenschr; 1981 Oct; 93(20):625-31. PubMed ID: 7324474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Review on internal medicine, 1973--nephrology. 6. Calcium metabolism in patients on regular dialysis treatment (author's transl)].
    Ogura Y
    Nihon Naika Gakkai Zasshi; 1974 Apr; 63(4):353-63. PubMed ID: 4605927
    [No Abstract]   [Full Text] [Related]  

  • 46. Hyperparathyroidism in the maintenance dialysis patient.
    Glassford DM; Remmers AR; Sarles HE; Lindley JD; Scurry MT; Fish JC
    Surg Gynecol Obstet; 1976 Mar; 142(3):328-32. PubMed ID: 1251311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
    Ix JH; Quarles LD; Chertow GM
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):337-9. PubMed ID: 16932455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Laboratory diagnosis of renal diseases. Modern views on the pathogenesis of uremic osteodystrophy. I].
    Jelonek A
    Przegl Lek; 1974; 31(8):758-62. PubMed ID: 4409945
    [No Abstract]   [Full Text] [Related]  

  • 49. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 50. 1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?
    Fournier A; Moriniere P; Boudaillez B; Renaud H; Marie A; Westeel PF; Hocine C; Belbrik S
    Nephrol Dial Transplant; 1987; 2(6):498-503. PubMed ID: 3126450
    [No Abstract]   [Full Text] [Related]  

  • 51. Brown tumor at the jaw in patients with secondary hyperparathyroidism due to chronic renal failure.
    Pechalova PF; Poriazova EG
    Acta Medica (Hradec Kralove); 2013; 56(2):83-6. PubMed ID: 24069663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of age and vitamin D deficiency on the uptake of alkaline earth metals by at bone.
    Dupuis Y; Gambier J
    Isr J Med Sci; 1971 Mar; 7(3):534-6. PubMed ID: 5567553
    [No Abstract]   [Full Text] [Related]  

  • 53. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Calcinosis in the renal transplant patient].
    Girard RM; Bastien E; Beaudry C; Dandavino R; Houde M; Laplante L
    Union Med Can; 1981 May; 110(5):443-51. PubMed ID: 7020201
    [No Abstract]   [Full Text] [Related]  

  • 55. [Secondary hyperparathyroidism in hemodialyzed uremic diabetic patients. Relatively less severe skeletal injuries].
    Bedani PL; Storari A; Tamarozzi R; Perazzini L; Farinelli A
    Minerva Urol Nefrol; 1986; 38(4):425-9. PubMed ID: 3589888
    [No Abstract]   [Full Text] [Related]  

  • 56. [Management of renal osteopathy in patients with chronic dialysis].
    Kiss D; Brunner FP
    Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chronic arthralgia in a 46-year-old patient with renal failure].
    Schiller B; Hillebrand G; Bartl R; Linke RP
    Internist (Berl); 1992 Feb; 33(2):117-21. PubMed ID: 1568827
    [No Abstract]   [Full Text] [Related]  

  • 58. Secondary hyperparathyroidism in chronic kidney disease: clinical consequences and challenges.
    Michael M; Garcia D
    Nephrol Nurs J; 2004; 31(2):185-94; quiz 195-6. PubMed ID: 15114799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy for ROD and measurement of the bone mass].
    Yamamoto I; Kawamura Y; Hirano K; Hayakawa H; Shigematu T
    Clin Calcium; 2004 Dec; 14(12):83-8. PubMed ID: 15577179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
    Yaginuma T; Yamamoto H
    Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.